AparnaBio welcomes the opportunity to collaborate with biomedical researchers in academia, government, and private industry to make our NanoElectroPlex™ technology available for the delivery of innovative and exciting therapeutic molecules. In these collaborations AparnaBio has the ability to accomodate its NanoElectroPlex™ nanoparticle to the collaborator’s experimental cargo(s) and target them to specific cells and tissues with specific cell surface receptors or antigens.

Development of partnerships with biotechnology and pharmaceutical companies is integral to AparnaBio’s business strategy. We welcome the opportunity to make our technology available for the delivery of therapeutic entities owned by potential partners. These relationships may be structured in a wide variety of mutually rewarding ways, can be staged to account for risk, and  match licensing costs to milestones achieved.

To explore collaborative and partnering and licensing opportunities contact:
Business Development at